03 August 2017
Sebia has launched a new product! Sebia FLC– The next generation assay for Serum Free Light Chain quantification bringing coherence with electrophoretic methods. The Sebia FLC Kappa & Sebia FLC Lambda kits allow the measurement of kappa and lambda free light chains (FLC) in human serum, either using a manual technique or a fully automated on the das AP22 ELITE ELISA processor. This test has been designed to overcome most of the proven analytical issues related to sFLC quantitative assays based on nephelometry/turbidimetry techniques (hook effect, high retest rate, short measuring range, lot-to-lot variability). It also solves most of the sFLC overestimation shown by historical techniques, giving results with better coherence to the “gold standard” for M-spike quantification: Serum Protein Electrophoresis.
For more information do visit http://www.sebia.com/en-EN/produits/sebia-flc